CARsgen Therapeutics Holdings Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

SEHK:2171 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
28 Jun 24	BuyHK$396,000	Huaqing Guo	Individual	80,000	HK$4.95
27 Jun 24	BuyHK$248,000	Huaqing Guo	Individual	50,000	HK$4.96
26 Jun 24	BuyHK$210,800	Huaqing Guo	Individual	42,500	HK$4.96
20 Jun 24	BuyHK$280,000	Huaqing Guo	Individual	50,000	HK$5.60
19 Jun 24	BuyHK$891,000	Huaqing Guo	Individual	150,000	HK$5.94
18 Jun 24	BuyHK$550,000	Huaqing Guo	Individual	100,000	HK$5.50
17 Jun 24	BuyHK$903,000	Huaqing Guo	Individual	150,000	HK$6.02
04 Jun 24	BuyHK$1,399,999	Huaqing Guo	Individual	200,000	HK$7.00
30 May 24	BuyHK$1,508,749	Huaqing Guo	Individual	212,500	HK$7.10
29 May 24	BuyHK$268,280	Huaqing Guo	Individual	38,000	HK$7.06
28 May 24	BuyHK$312,800	Huaqing Guo	Individual	46,000	HK$6.80
24 May 24	BuyHK$937,058	Huaqing Guo	Individual	142,000	HK$6.60
30 Apr 24	BuyHK$4,832,866	Huaqing Guo	Individual	815,000	HK$5.93

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 2171?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	28,290,324	5.15%
Institutions	75,716,881	13.8%
Private Companies	198,139,536	36.1%
General Public	246,741,674	45%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 55.02% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
36.1%	Yijie Biotech Holdings Limited	198,139,536	HK$1.8b	0%	no data
4.59%	AEGON-Industrial Fund Management Co. Ltd.	25,189,721	HK$227.5m	0%	0.15%
2.37%	The Vanguard Group, Inc.	13,010,000	HK$117.5m	0%	no data
1.62%	Bingsen Guo	8,888,888	HK$80.3m	0%	no data
1.62%	Xuehong Yang	8,888,888	HK$80.3m	0%	no data
1.56%	HSBC Jintrust Fund Management Company Limited	8,585,000	HK$77.5m	0%	0.25%
1.09%	Bosera Asset Management Co., Ltd.	5,981,000	HK$54.0m	0%	0.03%
1.01%	Xiaojing Guo	5,555,556	HK$50.2m	0%	no data
1%	Fullgoal Fund Management Co. Ltd.	5,467,500	HK$49.4m	0%	0.02%
0.9%	GF Fund Management Co., Ltd.	4,947,500	HK$44.7m	0%	0.01%
0.52%	Hua Jiang	2,880,992	HK$26.0m	0%	no data
0.52%	E Fund Management Co., Ltd.	2,833,810	HK$25.6m	0%	no data
0.44%	China Asset Management Co. Ltd.	2,423,830	HK$21.9m	-0.1%	no data
0.38%	Huaqing Guo	2,076,000	HK$18.7m	0%	no data
0.25%	Tianhong Asset Management Co., Ltd.	1,388,500	HK$12.5m	0%	0.01%
0.17%	Purekind Fund Management Co.,Ltd.	912,500	HK$8.2m	0%	0.11%
0.15%	Fullgoal Asset Management (HK) Limited	798,000	HK$7.2m	0%	0.34%
0.14%	Charles Schwab Investment Management, Inc.	753,236	HK$6.8m	19.6%	no data
0.13%	Norges Bank Investment Management	688,990	HK$6.2m	0%	no data
0.11%	China Universal Asset Management Company Ltd.	583,500	HK$5.3m	0%	no data
0.1%	Dimensional Fund Advisors LP	570,549	HK$5.2m	5.94%	no data
0.083%	Tebon Fund Management Co. Ltd.	455,000	HK$4.1m	0%	0.06%
0.076%	China Southern Asset Management Co., Ltd.	417,000	HK$3.8m	0%	no data
0.058%	U.S. Global Investors, Inc.	320,000	HK$2.9m	0%	0.02%
0.041%	State Street Global Advisors, Inc.	226,000	HK$2.0m	-0.88%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/31 05:24
End of Day Share Price	2024/12/31 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

CARsgen Therapeutics Holdings Limited is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Xiao Wei Lin	Everbright Securities Co. Ltd.
Ziyi Chen	Goldman Sachs